Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results

Syros Pharmaceuticals, Inc. (SYRS) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/02/2023 4 Roth David (Chief Medical Officer) has filed a Form 4 on Syros Pharmaceuticals, Inc.
Txns: Sold 7,348 shares @ $3.95, valued at $29k
07/18/2023 4 Olson Eric R (Chief Scientific Officer) has filed a Form 4 on Syros Pharmaceuticals, Inc.
Txns: Sold 689 shares @ $3.5, valued at $2.4k
06/02/2023 4 Young Richard A (Director) has filed a Form 4 on Syros Pharmaceuticals, Inc.
Txns: Granted 4,000 shares @ $0
Granted 6,000 options to buy @ $3.7, valued at $22.2k
06/02/2023 4 WIRTH PETER (Director) has filed a Form 4 on Syros Pharmaceuticals, Inc.
Txns: Granted 4,000 shares @ $0
Granted 6,000 options to buy @ $3.7, valued at $22.2k
06/02/2023 4 TYSON TIMOTHY (Director) has filed a Form 4 on Syros Pharmaceuticals, Inc.
Txns: Granted 4,000 shares @ $0
Granted 6,000 options to buy @ $3.7, valued at $22.2k
06/02/2023 4 OH ANDREW M. (Director) has filed a Form 4 on Syros Pharmaceuticals, Inc.
Txns: Granted 4,000 shares @ $0
Granted 6,000 options to buy @ $3.7, valued at $22.2k
06/02/2023 4 Fanucci Marsha (Director) has filed a Form 4 on Syros Pharmaceuticals, Inc.
Txns: Granted 4,000 shares @ $0
Granted 6,000 options to buy @ $3.7, valued at $22.2k
06/02/2023 4 Eckhardt Sue Gail (Director) has filed a Form 4 on Syros Pharmaceuticals, Inc.
Txns: Granted 4,000 shares @ $0
Granted 6,000 options to buy @ $3.7, valued at $22.2k
06/02/2023 4 Dunsire Deborah (Director) has filed a Form 4 on Syros Pharmaceuticals, Inc.
Txns: Granted 6,000 options to buy @ $3.7, valued at $22.2k
Granted 4,000 restricted stock units @ $0
06/02/2023 4 Alles Mark J (Director) has filed a Form 4 on Syros Pharmaceuticals, Inc.
Txns: Granted 6,000 options to buy @ $3.7, valued at $22.2k
Granted 4,000 restricted stock units @ $0
06/02/2023 4 AKKARAJU SRINIVAS (Director) has filed a Form 4 on Syros Pharmaceuticals, Inc.
Txns: Granted 6,000 options to buy @ $3.7, valued at $22.2k
Granted 4,000 restricted stock units @ $0
04/20/2023 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
04/20/2023 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
04/04/2023 4 Haas Jason (CFO) has filed a Form 4 on Syros Pharmaceuticals, Inc.
Txns: Paid exercise price by delivering 623 shares @ $2.58, valued at $1.6k
Exercised 2,000 restricted stock units @ $0
04/04/2023 4 Chee Conley (Chief Commercial Officer) has filed a Form 4 on Syros Pharmaceuticals, Inc.
Txns: Paid exercise price by delivering 658 shares @ $2.58, valued at $1.7k
Exercised 2,000 restricted stock units @ $0
04/04/2023 4 Roth David (Chief Medical Officer) has filed a Form 4 on Syros Pharmaceuticals, Inc.
Txns: Paid exercise price by delivering 623 shares @ $2.58, valued at $1.6k
Exercised 2,000 restricted stock units @ $0
04/04/2023 4 Stephens Kristin (Chief Development Officer) has filed a Form 4 on Syros Pharmaceuticals, Inc.
Txns: Paid exercise price by delivering 623 shares @ $2.58, valued at $1.6k
Exercised 2,000 restricted stock units @ $0
04/04/2023 4 Olson Eric R (Chief Scientific Officer) has filed a Form 4 on Syros Pharmaceuticals, Inc.
Txns: Paid exercise price by delivering 623 shares @ $2.58, valued at $1.6k
Exercised 2,000 restricted stock units @ $0
04/04/2023 4 Simonian Nancy A (President & CEO) has filed a Form 4 on Syros Pharmaceuticals, Inc.
Txns: Paid exercise price by delivering 1,852 shares @ $2.58, valued at $4.8k
Exercised 6,000 restricted stock units @ $0
10/13/2022 4 Quirk Gerald E (Chief Legal Officer) has filed a Form 4 on Syros Pharmaceuticals, Inc.
Txns: Granted 45,000 restricted stock units @ $0
10/13/2022 3 Quirk Gerald E (Chief Legal Officer) has filed a Form 3 on Syros Pharmaceuticals, Inc.
10/11/2022 4/A Chee Conley (Chief Commercial Officer) has filed a Form 4 on Syros Pharmaceuticals, Inc.
Txns: Granted 44,500 options to buy @ $6.73, valued at $299.5k
Granted 34,000 restricted stock units @ $0
10/11/2022 4 Chee Conley (Chief Commercial Officer) has filed a Form 4 on Syros Pharmaceuticals, Inc.
Txns: Granted 44,500 options to buy @ $6.73, valued at $299.5k
Granted 34,000 restricted stock units @ $0
10/11/2022 4 Stephens Kristin (Chief Development Officer) has filed a Form 4 on Syros Pharmaceuticals, Inc.
Txns: Granted 44,500 options to buy @ $6.73, valued at $299.5k
Granted 34,000 restricted stock units @ $0
10/11/2022 4 Olson Eric R (Chief Scientific Officer) has filed a Form 4 on Syros Pharmaceuticals, Inc.
Txns: Granted 44,500 options to buy @ $6.73, valued at $299.5k
Granted 34,000 restricted stock units @ $0
10/11/2022 4 Roth David (Chief Medical Officer) has filed a Form 4 on Syros Pharmaceuticals, Inc.
Txns: Granted 49,750 options to buy @ $6.73, valued at $334.8k
Granted 37,750 restricted stock units @ $0
10/11/2022 4 Haas Jason (CFO) has filed a Form 4 on Syros Pharmaceuticals, Inc.
Txns: Granted 49,750 options to buy @ $6.73, valued at $334.8k
Granted 37,750 restricted stock units @ $0
10/11/2022 4 Simonian Nancy A (President & CEO) has filed a Form 4 on Syros Pharmaceuticals, Inc.
Txns: Granted 115,000 options to buy @ $6.73, valued at $774k
Granted 80,250 restricted stock units @ $0
10/03/2022 4 TYSON TIMOTHY (Director) has filed a Form 4 on Syros Pharmaceuticals, Inc.
Txns: Bought 2,932 shares @ $5.7196, valued at $16.8k
Bought 14,000 shares @ $6.3704, valued at $89.2k
09/19/2022 4 Young Richard A (Director) has filed a Form 4 on Syros Pharmaceuticals, Inc.
Txns: Granted 12,000 options to buy @ $7.349, valued at $88.2k
Granted 8,000 restricted stock units @ $0
09/19/2022 4 WIRTH PETER (Director) has filed a Form 4 on Syros Pharmaceuticals, Inc.
Txns: Granted 8,000 shares @ $0
Granted 12,000 options to buy @ $7.349, valued at $88.2k
09/19/2022 4 TYSON TIMOTHY (Director) has filed a Form 4 on Syros Pharmaceuticals, Inc.
Txns: Granted 8,000 shares @ $0
Granted 12,000 options to buy @ $7.349, valued at $88.2k
09/19/2022 4 OH ANDREW M. (Director) has filed a Form 4 on Syros Pharmaceuticals, Inc.
Txns: Granted 8,000 shares @ $0
Granted 12,000 options to buy @ $7.349, valued at $88.2k
09/19/2022 4 Fanucci Marsha (Director) has filed a Form 4 on Syros Pharmaceuticals, Inc.
Txns: Granted 8,000 shares @ $0
Granted 12,000 options to buy @ $7.349, valued at $88.2k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy